查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2020280

動態療法（PDT）市場規模、佔有率、成長及全球產業分析：按類型、應用和地區分類，並預測至2026-2034年

Photodynamic Therapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 請詢問到貨日

價格

動態療法 (PDT) 市場的成長要素

全球動態療法（PDT）市場預計在2025年達到20.3億美元，2026年成長至21.8億美元，2034年達到40.3億美元，預測期內複合年成長率（CAGR）將達到7.97%。北美將在2025年引領區域市場，佔全球市場佔有率的37.02%。這主要得益於慢性病盛行率的上升、患者數量的成長以及主要企業對併購和產品創新的策略關注。

動態療法（PDT）利用氧氣、光能以及經光照射活化的天然或合成光敏劑來治療癌症、乾癬和日光性角化症等慢性疾病。慢性疾病（尤其是癌症）盛行率的上升促使診斷和治療率的提高，進而加速了PDT等先進治療方法的應用。

市場促進因素

慢性病盛行率的上升是推動成長要素。在美國，預計到2023年將新增約196萬例癌症病例，而乾癬患者超過800萬人，因此對有效治療方法的需求日益成長。包括量子點等奈米技術和生物相容性分子在內的技術進步正在提高光動力療法（PDT）的療效和患者預後。例如，Photonamic GmbH & Co KG與Lumeda, Inc.於2023年合作進行肺癌PDT臨床試驗，這些合作計畫體現了市場持續不斷的創新。

此外，隨著人們越來越傾向於微創治療方法，主要企業正在開發新的光敏劑和先進的醫療設備，以精確靶向病變細胞，同時最大限度地減少對健康組織的損害。

市場限制因素

儘管光動力療法具有這些優勢，但患者認知度較低，尤其是在新興市場，阻礙了市場成長。每次光動力療法治療費用高達約8500美元，進一步限制了其普及。此外，其他療法的出現降低了患者選擇光動力療法的迫切性，尤其是在醫學素養較低的地區。

細分分析

依產品類型：

光動力療法 (PDT) 市場分為光敏劑和動態療法 (PDT) 設備兩部分。預計光敏劑將成為市場成長的主要驅動力，到 2026 年將佔 65.03% 的市場佔有率，這主要得益於其微創性和療效提升等優勢。值得一核准的是，由博士倫和 Modelite 聯合核准。此外，由於人工智慧 (AI) 的整合和先進光源的應用，包括雷射和非雷射系統在內的 PDT 設備預計也將實現成長。

用途：

預計到2026年，癌症治療領域將佔54.63%的市場佔有率，成為市場主導領域。這主要得益於癌症發生率的上升，以及標靶治療和減少對健康細胞損傷等優勢。由於患者意識的提高和對創新治療方法需求的成長，日光性角化症、銀屑病和痤瘡治療領域預計將保持穩定成長。

按最終用戶分類：

到2026年，醫院將佔最大佔有率，達62.73%，這主要得益於住院人數的增加、報銷政策的調整以及光動力療法（PDT）在醫療機構中的廣泛應用。此外，由於新藥和新設備的上市，專科診所和其他終端用戶也預計將實現成長。

區域趨勢

  • 北美：預計2025年市場規模將達7.5億美元，2026年將達8.1億美元。其中，美國市場預計2026年將達到7.3億美元。這一成長是由慢性病患病率上升和主要企業的策略活動所推動的。
  • 歐洲：預計到 2025 年市場規模將達到 5.8 億美元，到 2026 年將達到 6.3 億美元，其中德國市場預計到 2026 年將達到 2.1 億美元，英國市場預計到 2026 年將達到 1.5 億美元。日光性角化症和其他皮膚病正在推動該技術的普及。
  • 亞太地區：預計到 2025 年市場規模將達到 4.5 億美元，到 2026 年將達到 4.8 億美元。日本、中國和印度由於人口老化和慢性病發病率不斷上升，對市場貢獻巨大。
  • 拉丁美洲、中東和非洲：預計拉丁美洲市場規模在2025年將達到1.5億美元，在2026年將達到1.6億美元；而中東和非洲市場規模在2025年將達到9000萬美元，在2026年將達到1億美元。成長的驅動力是品牌知名度的提升和新產品的推出。

主要企業及趨勢

光動力療法（PDT）市場正日趨集中，Biofrontera AG（德國）、Lumibird（法國）、Sun Pharmaceutical Industries Ltd.（印度）、Galderma（瑞士）和Bausch+Lomb（加拿大）等主要企業主導發展。近期進展包括：Biofrontera AG於2024年6月推出RhodeXL光動力療法燈；Galderma與German Medical Engineering於2023年2月達成合作；以及Better Therapeutics的AspyreRx於2023年7月獲得FDA核准。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家和地區主要疾病的流行情況
  • 動態療法設備的技術進步
  • 新產品發布
  • 產業重大發展動態：合併、收購、合作等。
  • 新冠疫情對市場的影響

第5章：2021-2034年全球動態療法（PDT）市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品類型分類
    • 光敏劑
      • 口服
      • 腸外
    • 動態療法（PDT）設備
      • 雷射
      • 非雷射
  • 市場分析、洞察與預測：按應用領域分類
    • 癌症
    • 日光性角化症
    • 粉刺
    • 銀屑病
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美動態療法（PDT）市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲動態療法（PDT）市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區動態療法（PDT）市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲動態療法（PDT）市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲動態療法（PDT）市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • BIOFRONTERRA AG
    • LUMIBIRD
    • Sun Pharmaceutical Industries Ltd.
    • GALDERMA
    • Bausch+Lomb
    • Luzitin, SA
    • Novartis AG
    • Modulight Corporation
    • Theralase Technologies Inc.
Product Code: FBI110441

Growth Factors of photodynamic therapy (PDT) Market

The global photodynamic therapy (PDT) market was valued at USD 2.03 billion in 2025 and is projected to grow to USD 2.18 billion in 2026, eventually reaching USD 4.03 billion by 2034, representing a robust CAGR of 7.97% during the forecast period. North America emerged as the leading regional market in 2025, capturing 37.02% of the global share, driven by the increasing prevalence of chronic diseases, growing patient admissions, and the strategic focus of key players on mergers, acquisitions, and product innovations.

Photodynamic therapy utilizes oxygen, light energy, and photosensitizing agents-either natural or synthetic-that become activated upon light exposure to treat chronic conditions such as cancer, psoriasis, and actinic keratosis. The rising prevalence of chronic disorders, particularly cancer, is driving higher diagnosis and treatment rates, thus fueling the adoption of advanced therapies like PDT.

Market Drivers

The increasing prevalence of chronic diseases is a major growth factor. In the U.S., approximately 1.96 million new cancer cases were projected in 2023, while over 8 million people are affected by psoriasis, reflecting rising demand for effective treatments. Technological advancements, including the integration of nanotechnology, such as quantum dots and biocompatible molecules, are improving PDT efficacy and patient outcomes. Collaborative efforts, such as Photonamic GmbH & Co KG partnering with Lumeda, Inc. in 2023 for lung cancer PDT trials, illustrate the ongoing innovation in the market.

Moreover, minimally invasive procedures are increasingly preferred, prompting key players to develop new photosensitizer drugs and advanced devices that target diseased cells precisely while minimizing harm to healthy tissue.

Market Restraints

Despite these advantages, limited patient awareness, especially in emerging markets, hinders market growth. High treatment costs, around USD 8,500 per PDT procedure, further constrain adoption. Additionally, the availability of alternative therapies reduces the urgency among patients to opt for PDT, particularly in regions with lower healthcare literacy.

Segmentation Analysis

By Product Type:

The PDT market is divided into photosensitizer drugs and photodynamic therapy devices. Photosensitizer drugs dominate with a 65.03% market share in 2026, driven by benefits such as minimal invasiveness and enhanced efficacy. Notable approvals include Bausch + Lomb and Modulight Corporation's VISUDYNE in February 2023. PDT devices, including laser and non-laser systems, are also expected to grow due to AI integration and advanced light sources.

By Application:

The cancer segment led with 54.63% market share in 2026, fueled by rising cancer prevalence and benefits like targeted therapy and reduced damage to healthy cells. Actinic keratosis, psoriasis, and acne segments are expected to grow steadily due to increasing patient awareness and demand for innovative therapies.

By End-User:

Hospitals accounted for the largest segment at 62.73% in 2026, supported by rising patient admissions, reimbursement policies, and increasing adoption of PDT in healthcare facilities. Specialty clinics and other end-users are also witnessing growth due to availability of novel drugs and devices.

Regional Insights

  • North America: Valued at USD 0.75 billion in 2025, projected to reach USD 0.81 billion in 2026, with the U.S. market expected at USD 0.73 billion in 2026. Growth is driven by chronic disease prevalence and strategic activities by key players.
  • Europe: Marketed at USD 0.58 billion in 2025, projected to reach USD 0.63 billion in 2026, with Germany at USD 0.21 billion and the U.K. at USD 0.15 billion in 2026. Actinic keratosis and other skin disorders drive adoption.
  • Asia Pacific: Valued at USD 0.45 billion in 2025, expected at USD 0.48 billion in 2026, with Japan, China, and India contributing significantly due to aging populations and rising chronic disorders.
  • Latin America & Middle East & Africa: Latin America was USD 0.15 billion in 2025, reaching USD 0.16 billion in 2026, and the Middle East & Africa contributed USD 0.09 billion in 2025, projected at USD 0.10 billion in 2026. Growth is driven by awareness and novel product launches.

Key Industry Players and Developments

The PDT market is consolidated, with key players like Biofrontera AG (Germany), Lumibird (France), Sun Pharmaceutical Industries Ltd. (India), Galderma (Switzerland), and Bausch + Lomb (Canada) leading. Recent developments include Biofrontera AG's RhodeXL lamp launch in June 2024, Galderma's collaboration with German Medical Engineering in February 2023, and Better Therapeutics' FDA approval for AspyreRx in July 2023.

Conclusion

The global photodynamic therapy market is poised for substantial growth between 2025 and 2034, fueled by rising chronic disease prevalence, technological advancements, and increasing adoption of minimally invasive procedures. While high costs and limited patient awareness pose challenges, strategic collaborations, innovative product launches, and regional expansion are expected to drive the market toward USD 4.03 billion by 2034.

Segmentation By Product Type

  • Photosensitizer Drugs
    • Oral
    • Parenteral
  • Photodynamic Therapy Devices
    • Laser
    • Non-Laser

By Application

  • Cancer
  • Actinic Keratosis
  • Acne
  • Psoriasis
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, Application, End-User, and Country)
    • U.S.
    • Canada
  • Europe (By Product Type, Application, End-User, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Application, End-User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Application, End-User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Application, End-User, and Country/Sub-region)
    • GCC South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025
  • 4.2. Technological Advancements in Photodynamic Therapy Devices
  • 4.3. New Product Launches
  • 4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.5. Impact of COVID-19 on the Market

5. Global Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Photosensitizer Drugs
      • 5.1.1.1. Oral
      • 5.1.1.2. Parenteral
    • 5.1.2. Photodynamic Therapy Devices
      • 5.1.2.1. Laser
      • 5.1.2.2. Non-Laser
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Cancer
    • 5.2.2. Actinic Keratosis
    • 5.2.3. Acne
    • 5.2.4. Psoriasis
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Photosensitizer Drugs
      • 6.1.1.1. Oral
      • 6.1.1.2. Parenteral
    • 6.1.2. Photodynamic Therapy Devices
      • 6.1.2.1. Laser
      • 6.1.2.2. Non-Laser
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cancer
    • 6.2.2. Actinic Keratosis
    • 6.2.3. Acne
    • 6.2.4. Psoriasis
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Photosensitizer Drugs
      • 7.1.1.1. Oral
      • 7.1.1.2. Parenteral
    • 7.1.2. Photodynamic Therapy Devices
      • 7.1.2.1. Laser
      • 7.1.2.2. Non-Laser
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cancer
    • 7.2.2. Actinic Keratosis
    • 7.2.3. Acne
    • 7.2.4. Psoriasis
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Photosensitizer Drugs
      • 8.1.1.1. Oral
      • 8.1.1.2. Parenteral
    • 8.1.2. Photodynamic Therapy Devices
      • 8.1.2.1. Laser
      • 8.1.2.2. Non-Laser
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cancer
    • 8.2.2. Actinic Keratosis
    • 8.2.3. Acne
    • 8.2.4. Psoriasis
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Photosensitizer Drugs
      • 9.1.1.1. Oral
      • 9.1.1.2. Parenteral
    • 9.1.2. Photodynamic Therapy Devices
      • 9.1.2.1. Laser
      • 9.1.2.2. Non-Laser
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cancer
    • 9.2.2. Actinic Keratosis
    • 9.2.3. Acne
    • 9.2.4. Psoriasis
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Photodynamic Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Photosensitizer Drugs
      • 10.1.1.1. Oral
      • 10.1.1.2. Parenteral
    • 10.1.2. Photodynamic Therapy Devices
      • 10.1.2.1. Laser
      • 10.1.2.2. Non-Laser
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Cancer
    • 10.2.2. Actinic Keratosis
    • 10.2.3. Acne
    • 10.2.4. Psoriasis
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. BIOFRONTERRA AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. LUMIBIRD
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Sun Pharmaceutical Industries Ltd.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. GALDERMA
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Bausch + Lomb
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Luzitin, S.A.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Novartis AG
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Modulight Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Theralase Technologies Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
  • Table 3: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
  • Table 4: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 6: Global Photodynamic Therapy Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 8: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
  • Table 9: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
  • Table 10: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: North America Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
  • Table 15: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
  • Table 16: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 18: Europe Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
  • Table 21: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
  • Table 22: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Asia Pacific Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
  • Table 27: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
  • Table 28: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 30: Latin America Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photosensitizer Drugs, 2021-2034
  • Table 33: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Photodynamic Therapy Devices, 2021-2034
  • Table 34: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 36: Middle East & Africa Photodynamic Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Photodynamic Therapy Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Photodynamic Therapy Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Photodynamic Therapy Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Photodynamic Therapy Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Photodynamic Therapy Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 7: North America Photodynamic Therapy Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Photodynamic Therapy Market Value Share (%), by Application, 2025
  • Figure 10: North America Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Photodynamic Therapy Market Value Share (%), by End User, 2025
  • Figure 12: North America Photodynamic Therapy Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Photodynamic Therapy Market Value Share (%), By Country, 2025
  • Figure 14: Europe Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 15: Europe Photodynamic Therapy Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Photodynamic Therapy Market Value Share (%), by Application, 2025
  • Figure 18: Europe Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Photodynamic Therapy Market Value Share (%), by End User, 2025
  • Figure 20: Europe Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Photodynamic Therapy Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Photodynamic Therapy Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Photodynamic Therapy Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 31: Latin America Photodynamic Therapy Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Photodynamic Therapy Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Photodynamic Therapy Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Photodynamic Therapy Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Photodynamic Therapy Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Photodynamic Therapy Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Photodynamic Therapy Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Photodynamic Therapy Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Photodynamic Therapy Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Photodynamic Therapy Market Share (%), By Company, 2025